Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi Supports UCSC Cancer Sequencing with Storage System, Funding

NEW YORK (GenomeWeb News) – The University of California, Santa Cruz said today that Hitachi has sponsored a new cancer genomics research agreement with the university, under which the company will provide research funding and a data storage system that together total over $1 million in support.

Hitachi Data Systems has provided a petabyte-capacity storage system that investigators will use to store and manage cancer genomics data and to study new methods for handling these types of data, UCSC said.

The UCSC researchers plan to use the funding and storage to conduct genome sequencing and analysis for the I-SPY 2 breast cancer trial, and they will work with partners at the University of California, San Francisco on the project.

The I-SPY 2 effort is focused on cases in which women who are newly diagnosed with locally advanced breast cancer are given investigational treatments based on molecular testing. The drugs are administered before surgery so investigators can see how they impact the tumors.

UCSC said it will use the support from Hitachi to add genomic data to the biomarkers that the partners are testing, which are to be used to predict patients' response to treatments.
The sequencing, analyses, and storage efforts involve several UCSC departments, including the Genome Technology Center, the Center for Research in Storage Systems (CRSS) and the Baskin School of Engineering.

The DNA and RNA sequencing of samples from the I-SPY 2 trial will be performed by investigators at the Genome Technology Center, who will compare sequencing from tumor and normal tissues from each patient with the goal of identifying the mutations that are causing these individual cancers.

Josh Stuart, a UCSC professor of biomolecular engineering who is leading the genome analysis component of the project, has been working together with a Hitachi researcher to jointly develop a new method for identifying genomic markers of drug sensitivity.

Stuart's lab is already using the petabyte Hitachi storage system, although the I-SPY 2 analysis has yet to begin.

"We're involved in a bioinformatics competition to predict breast cancer survival using gene expression data, and we were going to be mailing hard drives around the country to share data among participating groups until Hitachi stepped up to provide the storage system," Stuart said in a statement.

Hitachi is an industry sponsor of the CRSS, which is led by Executive Director Andy Hospodor, who is overseeing the Hitachi collaboration. Hospodor said the researchers aim to find ways to "reduce the footprint, improve the processing time, and minimize the bandwidth needed to move [genomics] data from one place to another."

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.